SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.48+1.4%Nov 14 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2083)1/4/2008 3:53:43 PM
From: Jibacoa  Read Replies (1) of 3722
 
NSTK Is also trying to find support at the $3.50 level.

bigcharts.marketwatch.com

The Nov30 L of $3.34 was below its March 2001 L of $3.88, but above its May 2001 L of $3.24 <g>

bigcharts.marketwatch.com

NSTK has 3 consecutive Qs of double digits lower revenues & higher losses. The EL for 2007 is around $2.10 vs. $1.72 in 2006

Back on Nov13, it announced that it was going to establish its subsidiary, MDRNA, as an independent company & was transferring its intellectual property related to RNAi into MDRNA, with the idea that MDRNA could obtain independent investments to fund its operations.

On Nov 7 was when the stock tanked after PG's decision to terminate the development and commercialization agreement for PTH1-34 Nasal Spray.

It seems that NSTK may get to test the $2.5 level.<g>

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext